Brian M. Baker

Brian M. Baker publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Brian M. Baker sits on this spectrum.

Brian M. Baker D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian M. Baker sits on this spectrum.

Best Publications

• Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.

  Yuan-Hua Ding;Brian M Baker;David N Garboczi;William E Biddison

  466
  Citations

• Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

  Fei Duan;Jorge Duitama;Sahar Al Seesi;Cory M. Ayres

  436
  Citations

• T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility.

  Oleg Y. Borbulevych;Kurt H. Piepenbrink;Brian E. Gloor;Daniel R. Scott

  257
  Citations

• The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site

  Amir R. Khan;Brian M. Baker;Partho Ghosh;William E. Biddison

  208
  Citations

• Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab

  Bharathi Vennapusa;Brian Baker;Marcin Kowanetz;Jennifer Boone

  186
  Citations

• Conversion of a T Cell Antagonist into an Agonist by Repairing a Defect in the TCR/Peptide/MHC Interface: Implications for TCR Signaling

  Brian M. Baker;Susan J. Gagnon;William E. Biddison;Don C. Wiley;Don C. Wiley

  177
  Citations

• TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms.

  Unknown

  171
  Citations

• Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.

  Julien Schmidt;Angela R. Smith;Morgane Magnin;Julien Racle;Julien Racle

  168
  Citations

• Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.

  Unknown

  164
  Citations

• Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance

  Zhiya Yu;Marc R. Theoret;Christopher E. Touloukian;Deborah R. Surman

  159
  Citations

• Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design

  Oleg Y. Borbulevych;Tiffany K. Baxter;Zhiya Yu;Nicholas P. Restifo

  147
  Citations

• Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand.

  Unknown

  137
  Citations

• Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity

  Jarrett J Adams;Jarrett J Adams;Samanthi Narayanan;Michael E Birnbaum;Sachdev S Sidhu

  135
  Citations

• T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome

  Unknown

  124
  Citations

• Identification of a Crucial Energetic Footprint on the α1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2–Specific T Cell Receptors

  Brian M. Baker;Richard V. Turner;Susan J. Gagnon;Don C. Wiley;Don C. Wiley

  119
  Citations

• Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.

  Oleg Y. Borbulevych;Francis K. Insaidoo;Tiffany K. Baxter;Daniel J. Powell

  112
  Citations

• Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance

  Unknown

  111
  Citations

• Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism

  Unknown

  104
  Citations

• Cutting Edge: Evidence for a Dynamically Driven T Cell Signaling Mechanism

  William F. Hawse;Matthew M. Champion;Michelle V. Joyce;Lance M. Hellman

  101
  Citations

• T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability.

  Timothy P Riley;Lance M Hellman;Marvin H Gee;Juan L Mendoza

  100
  Citations